학술논문

Arglabin, an EGFR receptor tyrosine kinase inhibitor, suppresses proliferation and induces apoptosis in prostate cancer cells
Document Type
Article
Source
In: Biomedicine and Pharmacotherapy. (Biomedicine and Pharmacotherapy, December 2022, 156)
Subject
Language
English
ISSN
19506007
07533322